{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:35:49Z","timestamp":1792802149970,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.beem.2021.101491","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T00:42:11Z","timestamp":1612658531000},"page":"101491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses"],"prefix":"10.1016","volume":"35","author":[{"given":"Nicholas","family":"Yozamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib2","volume":"41","author":"Sherlock","year":"2020","journal-title":"Adrenal Incidentaloma. Endocrine Reviews. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4158\/DSCR-2018-0565","article-title":"The evaluation of incidentally discovered adrenal masses","volume":"25","author":"Vaidya","year":"2019","journal-title":"Endocr Pract: Off J Am Coll Endocrinol Am Ass Clin Endocrinologists. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/cpt.1551","article-title":"Modern management of mild autonomous cortisol secretion","volume":"106","author":"Delivanis","year":"2019","journal-title":"Clin Pharmacol Therapeut. [Online]"},{"key":"10.1016\/j.beem.2021.101491_bib5","article-title":"Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion","author":"Foster","year":"2020","journal-title":"Surgery. [Online]"},{"key":"10.1016\/j.beem.2021.101491_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.3280","article-title":"Evaluation and treatment of patients with hypercortisolism: a review","author":"Miller","year":"2020","journal-title":"JAMA Surgery. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Annals Intern Med. [Online]"},{"issue":"9","key":"10.1016\/j.beem.2021.101491_bib8","doi-asserted-by":"crossref","first-page":"e3307","DOI":"10.1210\/clinem\/dgaa410","article-title":"Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors","volume":"105","author":"Singh","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online] Oxford Academic"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib9","article-title":"The impact of mild autonomous cortisol secretion on bone turnover markers","volume":"105","author":"Athimulam","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","article-title":"Clinical review: diagnosis and treatment of subclinical hypercortisolism","volume":"96","author":"Chiodini","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"11","key":"10.1016\/j.beem.2021.101491_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","article-title":"Prevalence and natural history of adrenal incidentalomas","volume":"149","author":"Barzon","year":"2003","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiol.2352031708","article-title":"Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer","volume":"235","author":"Benitah","year":"2005","journal-title":"Radiology. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J\u00a0Endocrinol Invest. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u2018incidentaloma\u2019)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Annals Intern Med. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib16","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocrine Reviews. [Online] Oxford Academic"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib17","first-page":"309","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocrine Reviews. [Online] Oxford Academic"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib18","first-page":"637","article-title":"A\u00a0survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib19","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"1","key":"10.1016\/j.beem.2021.101491_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature","volume":"171","author":"Boland","year":"1998","journal-title":"AJR. Am J Roentgenol. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-1056","article-title":"Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population","volume":"178","author":"Marty","year":"2018","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib22","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Management OF endocrine disease: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1148\/radiology.217.3.r00dc29798","article-title":"Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT","volume":"217","author":"Pe\u00f1a","year":"2000","journal-title":"Radiology. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.tem.2004.06.012","article-title":"Imaging evaluation of the non-functioning indeterminate adrenal mass","volume":"15","author":"Sahdev","year":"2004","journal-title":"TEM (Trends Endocrinol Metab): TEM. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib25","first-page":"711","article-title":"Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology","volume":"231","author":"Haider","year":"2004","journal-title":"Online"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2214\/ajr.165.6.7484585","article-title":"An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases","volume":"165","author":"McNicholas","year":"1995","journal-title":"AJR. Am J Roentgenol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12672-011-0089-z","article-title":"Conventional imaging in adrenocortical carcinoma: update and perspectives","volume":"2","author":"Young","year":"2011","journal-title":"Hormones & Cancer. [Online]"},{"issue":"9","key":"10.1016\/j.beem.2021.101491_bib28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"The Lancet. Diabetes & Endocrinology. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib29","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib30","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1210\/jc.2012-1061","article-title":"Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?","volume":"97","author":"Sane","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib31","first-page":"481","article-title":"A\u00a05-year prospective follow-up study of lipid-rich adrenal incidentalomas: No tumor growth or development of hormonal hypersecretion. Endocrinology and metabolism (seoul, korea)","volume":"30","author":"Schalin-J\u00e4ntti","year":"2015","journal-title":"Online"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib32","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib34","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol. [Online] BioScientifica"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME Position Statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol. [Online] BioScientifica"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib36","first-page":"1440","article-title":"Subclinical Cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","article-title":"Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study","volume":"70","author":"Vassilatou","year":"2009","journal-title":"Clin Endocrinol. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib38","first-page":"1","article-title":"NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u2018incidentaloma\u2019)","volume":"19","year":"2002","journal-title":"NIH consensus and state-of-the-science statements"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-016-1017-3","article-title":"Six controversial issues on subclinical Cushing\u2019s syndrome","volume":"56","author":"Chiodini","year":"2017","journal-title":"Endocrine. Online"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib40","first-page":"520","article-title":"Risk factors and long-term follow-up of adrenal incidentalomas","volume":"84","author":"Barzon","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib41","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.bjc.6602459","article-title":"Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas","volume":"92","author":"Bernini","year":"2005","journal-title":"Br J Can. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","article-title":"Long-term follow-up study of patients with adrenal incidentalomas","volume":"147","author":"Lib\u00e8","year":"2002","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MED.0000000000000159","article-title":"Update on subclinical Cushing\u2019s syndrome","volume":"22","author":"Nieman","year":"2015","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ecl.2005.01.008","article-title":"Subclinical Cushing\u2019s syndrome in adrenal incidentalomas","volume":"34","author":"Terzolo","year":"2005","journal-title":"Endocrinol Metabol Clin North America. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib45","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"The Lancet. Diabetes & Endocrinology. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/eje.0.1480213","article-title":"Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery","volume":"148","author":"Bernini","year":"2003","journal-title":"Eur J Endocrinol. Eur Soc Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.50.399","article-title":"Prevalence of subclinical Cushing\u2019s syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes","volume":"50","author":"Emral","year":"2003","journal-title":"Endocrine Journal. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2010.03794.x","article-title":"Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects","volume":"73","author":"Morelli","year":"2010","journal-title":"Clin Endocrinol. [Online]"},{"issue":"11","key":"10.1016\/j.beem.2021.101491_bib51","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing\u2019s syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanov\u00e0","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online] Oxford Academic"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/eje.1.01959","article-title":"Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma","volume":"153","author":"Terzolo","year":"2005","journal-title":"Eur J Endocrinol. [Online] Eur Soc Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib53","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy OF endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2021.101491_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1758-5996-2-71","article-title":"Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus","volume":"2","author":"Hiroi","year":"2010","journal-title":"Diabetology & Metabolic Syndrome. [Online]"},{"issue":"8","key":"10.1016\/j.beem.2021.101491_bib55","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u2018Nonfunctional\u2019 adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Annals Intern Med. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40618-014-0232-0","article-title":"Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism","volume":"38","author":"Masserini","year":"2015","journal-title":"J\u00a0Endocrinol Invest. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"5","key":"10.1016\/j.beem.2021.101491_bib58","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1210\/jc.2003-031413","article-title":"Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status","volume":"89","author":"Chiodini","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"9","key":"10.1016\/j.beem.2021.101491_bib59","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/jc.2009-0468","article-title":"Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study","volume":"94","author":"Chiodini","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"10","key":"10.1016\/j.beem.2021.101491_bib60","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/jbmr.1648","article-title":"Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism","volume":"27","author":"Eller-Vainicher","year":"2012","journal-title":"J\u00a0Bone Miner Res: Off J Am Soc Bone Min Res. [Online]"},{"issue":"1","key":"10.1016\/j.beem.2021.101491_bib61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2265.2003.01676.x","article-title":"Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?","volume":"58","author":"Hadjidakis","year":"2003","journal-title":"Clin Endocrinol. [Online]"},{"issue":"8","key":"10.1016\/j.beem.2021.101491_bib62","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jbmr.398","article-title":"Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study","volume":"26","author":"Morelli","year":"2011","journal-title":"J\u00a0Bone Miner Res: Off J Am Soc Bone Min Res. [Online]"},{"issue":"8","key":"10.1016\/j.beem.2021.101491_bib63","doi-asserted-by":"crossref","first-page":"e2770","DOI":"10.1210\/clinem\/dgaa270","article-title":"Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: a long-term study","volume":"105","author":"Di Dalmazi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online] Oxford Academic"},{"key":"10.1016\/j.beem.2021.101491_bib64","doi-asserted-by":"crossref","unstructured":"Morelli V, Ghielmetti A, Caldiroli A, et\u00a0al. Mental health in patients with adrenal incidentalomas: is there a relation with different degrees of cortisol secretion? J Clin Endocrinol Metabol. [Online]. Available from: doi:10.1210\/clinem\/dgaa695 [Accessed: 2 December 2020]","DOI":"10.1210\/clinem\/dgaa695"},{"issue":"12","key":"10.1016\/j.beem.2021.101491_bib65","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib66","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1056\/NEJMc1705984","article-title":"Diagnosis and differential diagnosis of Cushing\u2019s syndrome","volume":"377","author":"Loriaux","year":"2017","journal-title":"New En J Med. [Online]"},{"issue":"12","key":"10.1016\/j.beem.2021.101491_bib67","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4158\/EP161512.DSCR","article-title":"American association of clinical endocrinologists and American college of endocrinology disease state clinical review: diagnosis of recurrence incushing disease","volume":"22","author":"Fleseriu","year":"2016","journal-title":"Endocr Pract: Off J Am Coll Endocrinol Am Ass Clin Endocrinol. [Online]"},{"issue":"7","key":"10.1016\/j.beem.2021.101491_bib68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","article-title":"First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS","volume":"40","author":"Ceccato","year":"2017","journal-title":"J\u00a0Endocrinol Invest. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib69","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/jc.2018-01029","article-title":"Suppressed ACTH is frequently unrelated to autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"104","author":"Olsen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"9","key":"10.1016\/j.beem.2021.101491_bib70","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/JC.2015-1992","article-title":"Steroid profiling by LC-MS\/MS in nonsecreting and subclinical cortisol-secreting adrenocortical adenomas","volume":"100","author":"Di Dalmazi","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib71","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/cen.12295","article-title":"Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH","volume":"80","author":"Olsen","year":"2014","journal-title":"Clin Endocrinol. [Online]"},{"issue":"4","key":"10.1016\/j.beem.2021.101491_bib72","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-10-0962","article-title":"Assessment of ACTH assay variability: a multicenter study","volume":"164","author":"Pecori Giraldi","year":"2011","journal-title":"Eur J Endocrinol [Online]"},{"issue":"17","key":"10.1016\/j.beem.2021.101491_bib73","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1523\/JNEUROSCI.5332-09.2010","article-title":"Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males","volume":"30","author":"Russell","year":"2010","journal-title":"J Neurosci: Offl J Soc Neurosci. [Online]"},{"issue":"2","key":"10.1016\/j.beem.2021.101491_bib74","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2008-1542","article-title":"Late-night salivary cortisol for diagnosis of overt and subclinical Cushing\u2019s syndrome in hospitalized and ambulatory patients","volume":"94","author":"Nunes","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib75","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EJE-12-0803","article-title":"The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism","volume":"168","author":"Palmieri","year":"2013","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib76","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-07-0424","article-title":"Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing\u2019s syndrome","volume":"157","author":"Kidambi","year":"2007","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"1","key":"10.1016\/j.beem.2021.101491_bib77","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/EJE-08-0485","article-title":"The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma","volume":"160","author":"Masserini","year":"2009","journal-title":"Eur J Endocrinol. [Online]"},{"issue":"10","key":"10.1016\/j.beem.2021.101491_bib78","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2018-02349","article-title":"Plasma steroid profiles in subclinical compared with overt adrenal cushing syndrome","volume":"104","author":"Masjkur","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib79","first-page":"786","article-title":"Low dheas: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas","volume":"102","author":"Dennedy","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib80","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1373\/clinchem.2017.282582","article-title":"Plasma steroid metabolome profiling for diagnosis and subtyping patients with cushing syndrome","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem. [Online]"},{"issue":"12","key":"10.1016\/j.beem.2021.101491_bib81","first-page":"1824","article-title":"High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin Chem. [Online] Oxford Academic"},{"issue":"8","key":"10.1016\/j.beem.2021.101491_bib82","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Clinical practice guideline: treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online] Endocrine Soc"},{"issue":"8","key":"10.1016\/j.beem.2021.101491_bib83","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing\u2019s syndrome: a systematic review of the literature","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"},{"issue":"6","key":"10.1016\/j.beem.2021.101491_bib84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado","year":"2018","journal-title":"Clin Endocrinol. [Online]"},{"issue":"3","key":"10.1016\/j.beem.2021.101491_bib85","first-page":"540","article-title":"Use of morning serum cortisol level after transsphenoidal resection of pituitary adenoma to predict the need for long-term glucocorticoid supplementation","volume":"111","author":"Marko","year":"2009","journal-title":"J\u00a0Neurosurgery. [Online]"},{"issue":"9","key":"10.1016\/j.beem.2021.101491_bib86","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metabol. [Online]"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:28Z","timestamp":1761497788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1521690X21000087"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101491","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101491"}}